PB2637: OUR EXPERIENCE WITH AVATROMBOPAG TREATMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

por Cervinek, Libor
Publicado 2023

Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome

por Doubková, Martina, Vrzalová, Zuzana, Štefániková, Marianna, Červinek, Libor, Kozubík, Kateřina Staňo, Blaháková, Ivona, Pospíšilová, Šárka, Doubek, Michael
Publicado 2023

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

por Pulanić, Dražen, Bátorová, Angelika, Bodó, Imre, Červinek, Libor, Ionita, Ioana, Lissitchkov, Toshko, Melikyan, Anahit, Podolak-Dawidziak, Maria
Publicado 2023

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

por Janssens, Ann, Rodeghiero, Francesco, Anderson, David, Chong, Beng H., Boda, Zoltán, Pabinger, Ingrid, Červinek, Libor, Terrell, Deirdra R., Wang, Xuena, Franklin, Janet
Publicado 2016

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome

por Bereshchenko, Oxana, Lo Re, Oriana, Nikulenkov, Fedor, Flamini, Sara, Kotaskova, Jana, Mazza, Tommaso, Le Pannérer, Marguerite-Marie, Buschbeck, Marcus, Giallongo, Cesarina, Palumbo, Giuseppe, Li Volti, Giovanni, Pazienza, Valerio, Cervinek, Libor, Riccardi, Carlo, Krejci, Lumir, Pospisilova, Sarka, Stewart, A. Francis, Vinciguerra, Manlio
Publicado 2019